In the extracellular milieu, the presence of LOXL2 was found to enhance stromal stiffness and facilitate the promotion of adjacent fibroblasts, thereby establishing a supportive niche within the cancer microenvironment [50–52]. The gene discussed is LOXL2; the disease is cancer.